Contact Us
If you’re a member of the media working on a story about brain disorders or brain health, we can connect you with experts at Cohen Veterans Bioscience. Please don’t hesitate to contact us via email at press@cohenbio.org or by completing our online contact form here.
Mission Statement
Cohen Veterans Bioscience is a non-profit 501(c)(3) biomedical research and technology organization dedicated to advancing brain health by fast-tracking precision diagnostics and tailored therapeutics.
Explore the Archives
- News
Cohen Veterans Bioscience and 22 Jumps Announce Parachuting with Purpose: Recognizing the Epidemic of Veterans Suicide as a Result of Traumatic Brain Injury (TBI) and PTSD
Female Military Veterans BASE Jump Memorial Day Weekend in Twin Falls, Idaho to Raise Awareness and Funds.
- News
Cohen Veterans Bioscience and the European College of Neuropsychopharmacology Announce the 2023 Best Negative Data Prize in Clinical Neuroscience
– Sharing Negative Science Results Is Key to Neuroscience Advancement –
- News
Untapped potential of machine learning techniques for Parkinson’s Disease research and healthcare
Parkinson’s Progression Markers Initiative (PPMI): Review of a decade of research applying machine learning to the study of Parkinson’s disease diagnosis and progression.
- News
Cohen Veterans Bioscience Announces ‘Call for National TBI Action Coalition’
A new Community Coordination model to accelerate a first generation of diagnostics and treatments for Traumatic Brain Injury (TBI)
- News
Cohen Veterans Bioscience, the Scientific and Advocacy Leaders in TBI and PTSD, Applauds newly released film ‘Causeway’
New film starring Jennifer Lawrence depicts experience of U.S. Veteran with traumatic brain injury with scientific accuracy and depiction of invisible wounds
- News
Peter Hoehn, Accomplished Pharmaceutical Executive, Joins Cohen Veterans Bioscience (CVB) in Newly Created Executive Leadership Role
Peter Hoehn joins Cohen Veterans Bioscience (CVB) as Executive Vice President, Strategic Marketing, Development, and Impact. In this newly created role, Hoehn will lead the External Affairs, Communications, and Development
News
Cohen Veterans Bioscience and 22 Jumps Announce Parachuting with Purpose: Recognizing the Epidemic of Veterans Suicide as a Result of Traumatic Brain Injury (TBI) and PTSD
Female Military Veterans BASE Jump Memorial Day Weekend in Twin Falls, Idaho to Raise Awareness and Funds.
Learn More
News
Cohen Veterans Bioscience and the European College of Neuropsychopharmacology Announce the 2023 Best Negative Data Prize in Clinical Neuroscience
– Sharing Negative Science Results Is Key to Neuroscience Advancement –
Learn More
News
Untapped potential of machine learning techniques for Parkinson’s Disease research and healthcare
Parkinson’s Progression Markers Initiative (PPMI): Review of a decade of research applying machine learning to the study of Parkinson’s disease diagnosis and progression.
Learn More
News
Cohen Veterans Bioscience Announces ‘Call for National TBI Action Coalition’
A new Community Coordination model to accelerate a first generation of diagnostics and treatments for Traumatic Brain Injury (TBI)
Learn More
News
Cohen Veterans Bioscience, the Scientific and Advocacy Leaders in TBI and PTSD, Applauds newly released film ‘Causeway’
New film starring Jennifer Lawrence depicts experience of U.S. Veteran with traumatic brain injury with scientific accuracy and depiction of invisible wounds
Learn More
News
Peter Hoehn, Accomplished Pharmaceutical Executive, Joins Cohen Veterans Bioscience (CVB) in Newly Created Executive Leadership Role
Peter Hoehn joins Cohen Veterans Bioscience (CVB) as Executive Vice President, Strategic Marketing, Development, and Impact. In this newly created role, Hoehn will lead the External Affairs, Communications, and Development functions for New York-based non-profit CVB which is dedicated to advancing brain health.
Learn More
